CurrentCardio
Get Weekly

CurrentCardio coverage · page 7 of 21

European Journal of Preventive Cardiology

Briefs 241–280 of 816 CurrentCardio has covered from this journal, newest publication first

Latest from European Journal of Preventive Cardiology

All coverage, newest first

  1. Eur J Prev Cardiol

    Impact of PCSK9 inhibitors on lipoprotein(a) levels: a multi-centre study

    Cohort studyPrevention & lipids

  2. Eur J Prev Cardiol

    Elevated blood pressure levels among 533 167 adults living in Sub-Saharan Africa: a systematic review and meta-analysis

    Meta-analysisHypertension

  3. Eur J Prev Cardiol

    Anxiety and depression and secondary prevention of coronary heart disease in 14 countries across six WHO regions: the INTERASPIRE study

    Cross-sectional studyCoronary & ACS

  4. Eur J Prev Cardiol

    Comprehensive multiple risk factor control in cancer survivors to mitigate heart failure risk: insights from a prospective cohort study

    Cohort studyHeart failure

  5. Eur J Prev Cardiol

    Outcomes after coronary angiography in individuals with elevated lipoprotein(a)

    Cohort studyCoronary & ACS

  6. Eur J Prev Cardiol

    Polygenic prediction of coronary heart disease among 130 000 Mexican adults

    Cohort studyCoronary & ACS

  7. Eur J Prev Cardiol

    Type D personality, unhealthy behaviours, and 2-year outcomes after acute coronary syndrome: a cohort study

    Cohort studyCoronary & ACS

  8. Eur J Prev Cardiol

    Data-driven cluster analysis identifies distinct types of cardiovascular-kidney-metabolic syndrome

    Cohort studyCardiometabolic & kidney

  9. Eur J Prev Cardiol

    Risk of new-onset heart failure and heart failure exacerbations following COVID-19, influenza, or respiratory syncytial virus hospitalization

    Cohort studyHeart failure

  10. Eur J Prev Cardiol

    Secondary prevention education initiated in hospital for people with coronary heart disease: a systematic review and meta-analysis

    Meta-analysisCoronary & ACS

  11. Eur J Prev Cardiol

    Therapies leading to coronary atherosclerosis plaque regression: a scientific statement of the European Association of Preventive Cardiology, the European Association of Cardiovascular Imaging of the ESC, the ESC Working Group on Atherosclerosis and Vascular Biology, and the ESC Working Group on Cardiovascular Pharmacotherapy Part 2—drugs’ specific effect on atherosclerosis

    Guideline or statementCoronary & ACS

  12. Eur J Prev Cardiol

    Cardiopulmonary physical fitness and tissue characterization through T1 and T2 mapping: new insights on athlete’s heart

    Cross-sectional study

  13. Eur J Prev Cardiol

    Minimal extra-cardiac atherosclerosis present in young people with sudden cardiac death due to coronary artery disease

    Cohort studyCoronary & ACS

  14. Eur J Prev Cardiol

    Longitudinal trajectories of albuminuria and risk of subclinical and clinical heart failure, atrial fibrillation, and coronary heart disease: the MESA study

    Cohort studyHeart failure

  15. Eur J Prev Cardiol

    Comprehensive risk factor control in Type 2 diabetes and incident peripheral artery disease

    Cohort studyAortic & peripheral

  16. Eur J Prev Cardiol

    Exercise recommendations for patients with Marfan syndrome: an updated review

    Research articleAortic & peripheral

  17. Eur J Prev Cardiol

    Long-term ambient air pollution exposure and coronary calcium score in men: insights from the DANCAVAS study

    Cross-sectional studyPrevention & lipids

  18. Eur J Prev Cardiol

    Long-term prognosis of unrecognized myocardial infarction in women and men from the general population: the Rotterdam Study

    Cohort studyCoronary & ACS

  19. Eur J Prev Cardiol

    Impact of weight/BMI on clinical and bleeding events in 26 805 atrial fibrillation patients on edoxaban from the Global ETNA-AF Registry

    Cohort studyArrhythmias & EP

  20. Eur J Prev Cardiol

    Relationship of the healthy diet characteristics recommended by the 2021 ESC guidelines with vascular events in patients with established CVD

    Cohort studyPrevention & lipids

  21. Eur J Prev Cardiol

    Clinical significance of elevated lipoprotein(a) in primary and secondary prevention: a multi-institutional study

    Cohort studyPrevention & lipids

  22. Eur J Prev Cardiol

    Impact of remnant cholesterol on cardiovascular outcomes in non-myocardial infarction patients undergoing percutaneous coronary intervention

    Cohort study

  23. Eur J Prev Cardiol

    Tirzepatide and the prevention of heart failure in obesity: a multi-center cohort study using the TriNetX database

    Cohort studyHeart failure

  24. Eur J Prev Cardiol

    The role of lipoprotein(a) in predicting coronary artery disease among ageing endurance athletes and healthy controls

    Cross-sectional studyPrevention & lipids

  25. Eur J Prev Cardiol

    Differences in long-term impact of traditional risk factors for atherosclerosis on different arterial territories: insights from over 20 years of follow-up in the EPIC-Norfolk prospective population study

    Cohort studyPrevention & lipids

  26. Eur J Prev Cardiol

    Incidence and burden of cardiovascular disease attributable to extreme heat in China

    Cohort studyPrevention & lipids

  27. Eur J Prev Cardiol

    Predictors of long-term adverse course in acute myocarditis: a multicentre cohort study

    Cohort studyHeart failure

  28. Eur J Prev Cardiol

    Future myocardial infarction after an acute coronary syndrome and pharmacogenetic response to dalcetrapib

    Secondary analysisCoronary & ACS

  29. Eur J Prev Cardiol

    Genetic modelling of triglyceride-rich lipoprotein/remnant lowering mimics APOC3 silencing and predicts clinically relevant coronary heart disease event reductions

    Cohort studyPrevention & lipids

  30. Eur J Prev Cardiol

    Exercise-induced biomolecular changes and cardiovascular effects in heart failure: a systematic review and meta-analysis

    Meta-analysisHeart failure

  31. Eur J Prev Cardiol

    Exercise-based cardiac rehabilitation for coronary heart disease: the CaReMATCH individual participant data meta-analysis

    Meta-analysisCoronary & ACS

  32. Eur J Prev Cardiol

    Sex-specific disparities in lipid-based prediction of major cardiovascular events

    Cohort studyPrevention & lipids

  33. Eur J Prev Cardiol

    Accelerometer-derived ‘weekend warrior’ physical activity and incident cardiovascular disease among people with diabetes

    Cohort studyCardiometabolic & kidney

  34. Eur J Prev Cardiol

    Long-term impact of telemedicine for lipid control after an acute coronary syndrome

    Cohort studyCoronary & ACS

  35. Eur J Prev Cardiol

    Prognostic utility of the Global Leadership Initiative on Sarcopenia model in older patients with heart failure: post hoc analysis of the FRAGILE-HF study

    Secondary analysisHeart failure

  36. Eur J Prev Cardiol

    Social determinants of health in cancer survivors and the risk of cardiovascular events

    Cohort studyCardio-oncology & other

  37. Eur J Prev Cardiol

    Association of neutrophil-to-lymphocyte ratio with clinical outcomes after percutaneous coronary intervention

    Cohort studyCoronary & ACS

  38. Eur J Prev Cardiol

    Factors associated with elevated high-sensitivity C-reactive protein levels in individuals with atherosclerotic cardiovascular disease in the USA and the UK

    Cross-sectional studyPrevention & lipids

  39. Eur J Prev Cardiol

    Predicting cardiovascular events in allogeneic haematopoietic stem cell transplant recipients

    Cohort studyCardio-oncology & other

  40. Eur J Prev Cardiol

    One-year treatment trajectories of patients with statin intolerance: results from a multicentre registry

    Cohort studyPrevention & lipids

All 816 Briefs in ExploreShowing Briefs 241–280 of 816, newest first